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Carbon monoxide (CO) is a known, potent 
poisonous gas that causes hypoxaemia be-
cause of its high affinity for haemoglobin. 
It also induces inflammatory responses 
that cause tissue injury, particularly to the 
nervous and cardiovascular systems. Here 
we present a case of late-onset sick sinus 
syndrome (SSS) after CO poisoning. Ar-
rhythmia during the acute phase has been 
recorded in the literature, but to the best 
of our knowledge, this is the first report of 
late-onset SSS. Late-onset neuropathy after 
CO poisoning is well known, and it seems 
that a similar mechanism develops in car-
diac conduction after CO poisoning. This 
report highlights the importance of follow-
up for arrhythmia after CO poisoning. 
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INTRODUCTION 
Carbon monoxide (CO) intoxication is 
one of the most common types of poi-
soning worldwide. However, the underly-
ing mechanism of injury and treatment 
methods remains unclear. CO is a colour-
less, odourless, tasteless gas produced by 
incomplete combustion of carbonaceous 
material. CO forms carboxyhaemoglobin 
(COHb), which decreases oxygen trans-
port. Depending on the COHb level and 
exposure time, patients have various 
non-specific symptoms, ranging from 
headache, myalgia and dizziness to se-
vere conditions, such as unconsciousness 
and eventually death. (1) Lack of clinical 
specificity often leads to CO poisoning be-
ing overlooked or misdiagnosed. In addi-
tion to these acute-phase symptoms, neu-
ropathy and psychiatric disorders are well 
known. (1) Neuropsychological sequelae 
occur at 6 weeks after poisoning in 46% 
patients. (2) However, we have not paid 
attention to arrhythmias after CO poison-
ing as much. Here we report a case of late-
onset sick sinus syndrome (SSS) after CO 
poisoning.
CASE PRESENTATION 
An 87-year-old Japanese woman was 
found unconscious in a room with a bri-
quette heater and was brought to our hos-
pital. She had been exposed to CO for at 
least 12 h. She was under treatment for 
high blood pressure and Hashimoto dis-
ease, without arrhythmia. Medical exami-
nation findings obtained 4 months earlier, 
including electrocardiogram (ECG) re-
sults, revealed no abnormalities. On ad-
mission, her initial Glasgow Coma Scale 
score was 6/15 (E1V1M4), her pupils were 
3/3 mm and her pupillary reflex was slow/
slow (right/left). Her blood pressure was 
162/69 mmHg, but other vital signs were 
non-specific. Physical examination re-
vealed no abnormalities. The results of lab-
oratory studies, including routine haemo-
gram, electrolyte level, blood sugar levels 
and thyroidal function, were in the normal 
range. The troponin I level was 0.008 ng/
mL, creatinine kinase level was 135 IU/L, 
and ECG showed normal cardiac function 
(figure 1). Myocardial damage was not sus-
pected. Blood gas tests showed pH 7.394, 
PO2 level of 194.0 mmHg, PCO2 level of 
43.4 mmHg, HCO3 level of 25.9 mmHg, 
base excess level of 1.2 mmol/L and COHb 
level of 16.0%. The actual COHb level 
may have been higher than the measured 
level because she already had been treat-
ed with an oxygen reservoir mask (10 L/
min) for 30 min during time spent in the 
ambulance. Brain computed tomography 
revealed no cerebral infarction or haemor-
rhagic lesions. We diagnosed her with CO 
poisoning, and hyperbaric oxygen therapy 
(HBO) was initiated and continued for 5 
days. Her level of consciousness gradually 
improved, and she was shifted from the in-
tensive care unit on day 5. On day 13, she 
developed bradycardia, with a heart rate 
between 30 and 40 beats/min; however, 
she did not have any symptoms. Sinus ar-
rest occurred for 5 s at midnight on the fol-
lowing day (figure 2). The next day, a pro-
longed RR interval (maximum, 4.08 s) was 
detected by Holter electrocardiography. 
Echocardiography showed no dilatation, 
and the ejection fraction was 77.1%. She 
was diagnosed with SSS, and a pacemaker 
was implanted. The pacemaker was set at 
60 beats/min and no spontaneous rhythm 
was noted thereafter. She did not develop 
other late-onset neurologic injuries, such 
as dementia, parkinsonism or changes in 
the globus pallidus on magnetic resonance 
imaging.
DISCUSSION
In this case, the patient experienced late-
onset SSS after CO poisoning. Before hos-
pitalisation and even after hospitalisation, 
the patient had a normal sinus rhythm, 
but she gradually developed bradycardia, 
which progressed to SSS over the course of 
approximately 2 weeks.
CO functions as a neurotransmitter in 
physiologic amounts. It modulates inflam-
mation, (3) apoptosis (4) and cell prolif-
eration (5) and upregulates mitochondrial 
biogenesis. (6) CO has 200 times higher 
affinity for haemoglobin than oxygen and 
forms COHb, which decreases oxygen 
transport at a high level. It also causes a 
leftward shift of the oxyhaemoglobin dis-
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sociation curve and promotes oxygen 
deficiency. In addition, CO binds to cy-
tochrome c oxidase and interrupts cellular 
respiration, resulting in the production of 
reactive species, which leads to necrosis 
and apoptosis. Apart from that, inflam-
matory mechanisms have been discussed. 
These mechanisms, including unidentified 
ones, damage nearly all the organs and tis-
sues, particularly in the central nervous 
and cardiovascular systems. (1) The car-
diac conduction system is part of the nerv-
ous system; the mechanism of injury to 
this system may be similar to that of late-
onset injury to the central nervous system. 
Considering the similarity between these 
mechanisms, neuropathy and arrhythmia 
should be correlated. However, the reason 
underlying the development of only SSS 
and no brain injury in our case remains 
unclear. Neurological injuries have not yet 
been elucidated, and there is also a report 
that COHb values correlate poorly with 
neurologic injuries. The pathogenesis and 
risk factors for delayed neurologic injuries 
remain unknown. (7)
Myocardial ischaemia and injury may oc-
cur in the acute phase, and ECG and cardi-
ac enzyme tests are recommended. (1,8) In 
a study on patients with moderate to severe 
CO poisoning, 37% had elevated cardiac 
enzymes and/or diagnostic ECG changes. 
(9) However, there were no abnormalities 
in our case. A cohort study demonstrated 
a possible correlation between CO poison-
ing and the risk of developing arrhythmia 
on long-term observation. Arrhythmia 
was the most common cause of death after 
the acute phase, with paroxysmal tachycar-
dia as the most frequent (24%), followed 
by ventricular fibrillation or flutter (15%) 
and paroxysmal supraventricular tachycar-
dia (7%). (10) 
HBO is an effective therapy for CO poi-
soning. (1) However, during HBO, elec-
tronic devices, such as monitors, cannot be 
used because of the risk of fire. In the event 
of lethal arrhythmias during HBO admin-
istration, because the pressure inside the 
capsule is high, we cannot immediately 
attend to the patient; this lag in treatment 
due to waiting for the pressure to decrease 
may lead to patient’s death in some cases. 
The patient’s cardiac function should be 
checked before administering HBO.
This case showed the possibility of late-
onset lethal arrhythmia in patients with 
CO poisoning. Reports of the long-term 
outcome in patients with CO poisoning 
are limited, but CO poisoning is associated 
with increased mortality and arrhythmia. 
(10) Thus, follow-up observation is neces-
sary. 
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Figure 1. ECG result on admission showed normal sinus rhythm
Figure 2. On day 14, sinus arrest occurred for 5 seconds.
